Showing results (71-80 of 169) with videos related to
Sort By:
Pageof 17
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2007
Lymphoma immunotherapy with CpG oligodeoxynucleotides requires TLR9 either in the host or in the tumor itselfJiali Li, Wenru Song, Debra K Czerwinski, et al.Immunotherapy|May 31, 2012
Combination strategies to enhance antitumor ADCCHolbrook E Kohrt, Roch Houot, Aurélien Marabelle, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 20, 2020
Intratumoral Immunotherapy for Early-stage Solid TumorsWan Xing Hong, Sarah Haebe, Andrew S Lee, et al.Proceedings of the National Academy of Sciences of the United States of America|August 10, 2012
A vaccine directed to B cells and produced by cell-free protein synthesis generates potent antilymphoma immunityPatrick P Ng, Ming Jia, Kedar G Patel, et al.Proceedings of the National Academy of Sciences of the United States of America|March 3, 2015
Therapeutic antitumor immunity by checkpoint blockade is enhanced by ibrutinib, an inhibitor of both BTK and ITKIdit Sagiv-Barfi, Holbrook E K Kohrt, Debra K Czerwinski, et al.Blood|September 30, 2010
A CpG-loaded tumor cell vaccine induces antitumor CD4+ T cells that are effective in adoptive therapy for large and established tumorsMatthew J Goldstein, Bindu Varghese, Joshua D Brody, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 31, 2023
Targeted TLR9 Agonist Elicits Effective Antitumor Immunity against Spontaneously Arising Breast TumorsCaitlyn L Miller, Idit Sagiv-Barfi, Patrick Neuhöfer, et al.Science Translational Medicine|February 2, 2018
Eradication of spontaneous malignancy by local immunotherapyIdit Sagiv-Barfi, Debra K Czerwinski, Shoshana Levy, et al.Blood Cancer Discovery|November 15, 2021
How to Provide the Needed Protection from COVID-19 to Patients with Hematologic MalignanciesAntoni Ribas, Madhav V Dhodapkar, Katie M Campbell, et al.The Journal of Experimental Medicine|May 25, 2019
CD81 is a novel immunotherapeutic target for B cell lymphomaFelipe Vences-Catalán, Chiung-Chi Kuo, Ranjani Rajapaksa, et al.Pageof 17